Research and Development

Ipsen has appointed Claude Bertrand (pictured) chief scientific officer and Jacques-Pierre Moreau chief scientific advisor.Bertrand moves to the company next …

Quintiles has agreed to set up a clinical research unit in London that will allow it to tap into the …

Another report concluding that the most successful contract research organisations (CROs) will be those that can offer a broad range …

Pharmafocus' round-up of contract research news includes ICON's Q3 results, expansion plans at ClinTec and a prestigious award for Bilcare

A nasal spray technology which promises an alternative drug delivery method for biologic drugs has been given a funding boost. …

Syntaxin, a biopharmaceutical company developing novel biologic drugs that control cell secretion, has appointed Andrew Sandham executive chairman.This follows the …

French genome engineering company Cellectis has appointed Dr Sylvie Delassus senior vice president communications and a member of its executive …

Contract research organisation Quintiles has launched a website for people considering participating in clinical trials. The company hopes Clinicalresearch.com will …

 GlaxoSmithKline’s Votrient has been approved in the US by the FDA to treat the most common form of kidney cancer.This …

 The completion of Pfizer’s deal to acquire Wyeth has been followed swiftly by news that a number of manufacturing and …

Just two years ago it cost $10m to sequence a human genome, now for $48,000 you can have a personal …

MorphoSys has appointed Dr Lisa Rojkjaer as vice president and head of clinical development. Dr Rojkjaer joins MorphoSys from Novartis …

GlaxoSmithKline, the government and the Wellcome Trust are collaborating to build what they hope will be a "world-class" science park. …

 Merck KGaA has bought an Indian company specialising in research products in a deal it says will make it one …

GlaxoSmithKline's urinary treatment Avodart works better as part of a combination therapy, according to a new survey. The drug was …